Reversible Pulmonary Artery Hypertension in Association with Interferon-beta Therapy for Multiple Sclerosis
Overview
Overview
Journal
Iran J Neurol
Publisher
Tehran University of Medical Sciences
Date
2016 May 4
PMID
27141277
Citations
2
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Atabati E, Dehghani-Samani A, Mortazavimoghaddam S Can J Respir Ther. 2020; 56:1-9.
PMID: 33274259 PMC: 7690312. DOI: 10.29390/cjrt-2020-021.
Pulmonary arterial hypertension associated with interferon therapy: a population-based study.
Papani R, Duarte A, Lin Y, Kuo Y, Sharma G Multidiscip Respir Med. 2017; 12:1.
PMID: 28105332 PMC: 5240202. DOI: 10.1186/s40248-016-0082-z.
References
1.
George P, Badiger R, Alazawi W, Foster G, Mitchell J
. Pharmacology and therapeutic potential of interferons. Pharmacol Ther. 2012; 135(1):44-53.
DOI: 10.1016/j.pharmthera.2012.03.006.
View
2.
Gibbons E, Promislow S, Davies R, Chandy G, Stewart D, Vladamir C
. Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis. Can Respir J. 2015; 22(5):263-5.
PMC: 4596647.
DOI: 10.1155/2015/181535.
View
3.
Govern E, Judge E, Kavanagh E, Gaine S, Lynch T
. Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?. Mult Scler Relat Disord. 2015; 4(3):284-6.
DOI: 10.1016/j.msard.2015.03.008.
View
4.
Caravita S, Secchi M, Wu S, Pierini S, Paggi A
. Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: a case report. Cardiology. 2012; 120(4):187-9.
DOI: 10.1159/000335064.
View
5.
Rot U, Horvat Ledinek A
. Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis. Clin Neurol Neurosurg. 2013; 115 Suppl 1:S79-81.
DOI: 10.1016/j.clineuro.2013.09.027.
View